Loading...

Hydrix Limited

HYD.AXASX
TechnologyHardware, Equipment & Parts
A$0.01
A$0.00(0.00%)

Hydrix Limited (HYD.AX) Stock Overview

Explore Hydrix Limited’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
-19.20%
19.20%
Profit Growth
A$-0.02
2308.22%
EPS Growth
A$-0.02
2111.76%
Operating Margin
-3.88%
64.50%
ROE
178.99%
2308.22%
Dividend Yield
0.00%
Analyst Recommendations data is not available for HYD.AXAnalyst Recommendations details for HYD.AX are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Hydrix Limited provides product design, engineering, and regulatory services in Australia, Singapore, Europe, North America, and internationally. It operates through two segments: Hydrix Services and Hydrix Medical. It provides cardiovascular products, such as The GUARDIAN, a cardiac monitoring and alerting device that reduces the stresses of living; Phyzhon PHYRARI FFR-Wire enables cardiologists to combine diagnosis procedures with delivery of therapy including stents; and LUDO, a customizable plug-and-play platform that provides critical tools to start MCS pump development. The company also offers a range of services, including product development, regulatory and clinical consulting, and technology commercialization. It serves medical, consumer, industrial, utilities, defense, aerospace, and mining industries. The company was formerly known as Panorama Synergy Limited and changed its name to Hydrix Limited in November 2018. Hydrix Limited was incorporated in 1993 and is headquartered in Mulgrave, Australia

CEO

Mr. Gavin Coote

Employees

55

Headquarters

30-32 Compark Circuit, Mulgrave, VIC

Founded

2001

Frequently Asked Questions